Literature DB >> 3068821

Pharmacologic management of keratomycoses.

K J Johns1, D M O'Day.   

Abstract

Fungal corneal infections can be very difficult to treat. An evolving understanding of the pharmacology of the currently available antifungal agents has led to improved medical treatment of the keratomycoses. The pharmacology, pharmacokinetics, spectrum of activity and toxicity of these agents is reviewed and promising new antifungal compounds and modes of treatment are discussed.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3068821     DOI： 10.1016/0039-6257(88)90086-0

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN： 0039-6257            Impact factor:   6.048


  12 in total

1.  Amniotic membrane transplantation for necrotising conjunctival ulceration following subconjunctival atropine injection.

Authors:  K Y Seo; C Y Kim; J H Lee; J B Lee; E K Kim
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

2.  Diagnosis of Fusarium keratitis in an animal model using the polymerase chain reaction.

Authors:  G Alexandrakis; S Jalali; P Gloor
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

3.  Sporothrix schenckii endophthalmitis presenting as granulomatous uveitis.

Authors:  M J Cartwright; M Promersberger; G A Stevens
Journal:  Br J Ophthalmol       Date:  1993-01       Impact factor: 4.638

4.  Orally administered antifungal therapy for experimental keratomycosis.

Authors:  D M O'Day
Journal:  Trans Am Ophthalmol Soc       Date:  1990

5.  Fungal scleral keratitis caused by Phomopsis phoenicicola.

Authors:  Devarshi U Gajjar; Anuradha K Pal; Trilok J Parmar; Anshul I Arora; Darshini A Ganatra; Forum B Kayastha; Bharat K Ghodadra; Abhay R Vasavada
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

6.  A prototype antifungal contact lens.

Authors:  Joseph B Ciolino; Sarah P Hudson; Ashley N Mobbs; Todd R Hoare; Naomi G Iwata; Gerald R Fink; Daniel S Kohane
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-09       Impact factor: 4.799

Review 7.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

8.  Toxicities and pharmacokinetics of subconjunctival injection of liposomal amphotericin B.

Authors:  Yuichi Kaji; Erika Yamamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-29       Impact factor: 3.117

Review 9.  [Keratomycosis: diagnosis and therapy].

Authors:  W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

10.  Effect of formulation factors on in vitro transcorneal permeation of voriconazole from aqueous drops.

Authors:  Biswaranjan Mohanty; Sagar Kumar Mishra; Dipak K Majumdar
Journal:  J Adv Pharm Technol Res       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.